Lotilaner ophthalmic solution, 0.25%
TRS-023
Approved small_molecule completed
Quick answer
Lotilaner ophthalmic solution, 0.25% for Demodex Blepharitis is a Approved program (small_molecule) at Tarsus Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tarsus Pharmaceuticals
- Indication
- Demodex Blepharitis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed